Publications by authors named "Nargues Yasa"

3 Publications

  • Page 1 of 1

Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by Ziziphora clinopoides (Kahlioti); a molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice.

Toxicol Mech Methods 2009 Feb;19(2):183-9

Laboratory of Toxicology, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Inflammatory bowel disease (IBD) is a chronic condition of the intestine with unknown etiology involving multiple immune genetic and environmental factors. The authors were interested in examining the protective effect of Ziziphora clinopoides methanolic extract, an Iranian folk herbal medicine, on inflammatory mediators in experimental colitis. Colitis in NMRI mice was induced by oral administration of dextran sodium sulfate (DSS, 3%). Z. clinopoides was administrated orally at doses of 75, 150, and 300 mg/kg/day for 7 days. The level of lipid peroxidation (LP), total antioxidant capacity (TAC), total thiol molecules (TTM), antioxidant enzymes including superoxide dismutase (SOD) and catalase (CAT), and nitric oxide (NO) as a marker of nitrosative stress, and tumor necrosis factor alpha (TNF-alpha) as a mediator of inflammation and apoptosis were measured in the colon homogenate. Treatment by DSS increased bowel LP, NO, and TNF-alpha while decreasing TAC, SOD, CAT, and TTM. All measured parameters were improved by Z. clinopoides treatment and reached close to normal levels. The present study further supports the role of oxidative/nitrosative stresses and TNF-alpha in the pathogenesis of colitis and protective effects of this herb. The data are promising for further preclinical studies directed towards understanding mechanism of action and cross-species and cross-model comparisons for potential protective effects.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1080/15376510701533996DOI Listing
February 2009

Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial.

Evid Based Complement Alternat Med 2010 Dec 27;7(4):465-70. Epub 2008 Feb 27.

Faculty of Pharmacy and Pharmaceutical Sciences Research Center (PSRC), Endocrinology and Metabolism Research Center (EMRC) and Faculty of Medicine, Medicinal Plants Research Center (MPRC), Tehran University of Medical Sciences (TUMS) and Drug Selecting Committee, Food and Drug Organization, and Food and Drug Laboratory Research Center, Tehran, Iran.

Satureja khuzestanica is an endemic plant of Iran that is widely distributed in the Southern part of the country. It has antioxidant properties and thus it seems to be useful in diseases related to oxidative stress such as diabetes and hyperlipidemia. The present study investigates the effect of S. khuzestanica supplement in metabolic parameters of hyperlipidemic patients with type 2 diabetes mellitus. Twenty-one hyperlipidemic patients with type 2 diabetes mellitus were randomized in a double blind, placebo controlled clinical trial to receive either S. khuzestanica (tablets contain 250 mg dried leaves) or placebo once a day for 60 days. Blood samples were obtained at baseline and at the end of the study. Samples were analyzed for levels of glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, creatinine, thiobarbituric acid reactive substances (TBARS) as marker of lipid peroxidation and ferric reducing ability (total antioxidant power, TAP). Treatment of patients by S. khuzestanica for 60 days induced significant decrease in total cholesterol (P = 0.008) and LDL-cholesterol (P = 0.03) while increased HDL-cholesterol (P = 0.02) and TAP (P = 0.007) in comparison with the baseline values. S. khuzestanica did not alter blood glucose, triglyceride, creatinin and TBARS levels. In comparison with baseline values, no significant change was observed in blood glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, creatinine, TBARS and TAP in placebo-treated group. Usage of S. khuzestanica as a supplement to drug regimen of diabetic type 2 patients with hyperlipidemia is recommended.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecam/nen018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892343PMC
December 2010

In vivo antioxidant potential of Teucrium polium, as compared to alpha-tocopherol.

Acta Pharm 2007 Mar;57(1):123-9

Laboratory of Toxicology, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.

The present study was undertaken to explore antioxidant potential of Teucrium polium (Lamiaceae) in vivo. Antioxidant activity was measured by three tests including inhibition of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical, total antioxidant power (TAP), and thiobarbituric acid reactive substances (TBARS) in serum. Rats received dry extract of T. polium in 80% ethanol by intragastric intubation at doses of 50, 100 and 200 mg kg(-1) daily for 14 days. Treatment of rats with T. polium extract showed significant antioxidant activity in the DPPH test as compared to the control. T. polium extract at doses of 50 and 100 mg kg(-1) significantly increased rats TAP and decreased TBARS compared to the control. Administration of T. polium at a dose of 200 mg kg(-1) per day did not significantly alter serum TAP and TBARS. Antioxidant activities of T. polium at a doses of 50 and 100 mg kg(-1) were in all experiments comparable to that of alpha-tocopherol (10 mg kg(-1)).
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.2478/v10007-007-0010-zDOI Listing
March 2007